Whole-Exome Sequencing Analysis of Inflammatory Bowel Disease-Associated Serrated Dysplasia
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26125704 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Zsófia Balajthy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Albert Szent-Györgyi Medical School, University of Szeged, 6725 Szeged, Hungary. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Exome Sequencing, Colorectal Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Szeged, Albert Szent-Györgyi Medical School, Faculty Research Fund, Géza Hetényi Fund.
Abstract (Originalsprache)
The clinicopathologic and molecular features of serrated lesions with dysplasia in inflammatory bowel disease (IBD) remain poorly understood. We examined a total of 2396 patients treated for IBD at the University of Szeged between 2011 and 2023. Among them, 177 (7%) patients were diagnosed with colorectal neoplasia, of which only 11 (6%) had serrated dysplasia (n = 13). Of the 13 lesions, 5 (38%) showed features of sessile serrated lesion (SSL)-like dysplasia; 1 (8%) exhibited characteristics of traditional serrated adenoma (TSA)-like dysplasia; 6 (46%) were classified as serrated dysplasia, not otherwise specified (NOS); and 1 (8%) displayed mixed features of SSL-like and TSA-like dysplasias. At the time of the serrated dysplasia diagnosis, the mean age of the patients was 56 years. Ten (91%) patients had ulcerative colitis, and one (9%) had Crohn’s disease. Pancolitis was observed in seven (64%) patients. The mean duration of IBD at the time of the serrated dysplasia diagnosis was 26 years. Most lesions (n = 9; 69%) were found in the left colon, including SSL-like dysplasia (3/5; 60%) and serrated dysplasia NOS (5/6, 83%). Eleven (85%) lesions had a polypoid endoscopic appearance. The mean size of the serrated dysplasia was 0.8 cm. Most lesions (n = 8; 62%) showed low-grade dysplasia. Serrated dysplasia was often associated with conventional (n = 3; 27%) or nonconventional dysplasia (n = 3; 27%). During the follow-up, 5 (45%) of the 11 patients developed colorectal cancer, including 3 patients with serrated dysplasia NOS, 1 with SSL-like dysplasia, and 1 with TSA-like dysplasia. Whole-exome sequencing revealed that the SSL-like dysplasia harbored mutations in BRAF (p.V600E), MLH1, KRAS, PTEN, POLE, KMT2C, and/or EXT1, whereas the serrated dysplasia NOS showed mutations in TP53, POLG, BRAF (p.G469A), KMT2C, and/or EXT1. One patient with both SSL-like dysplasia and mixed SSL-like/TSA-like dysplasia carried a pathogenic MUTYH (p.R217H) mutation, along with mutations in MADD. Serrated dysplasia was rare in IBD, with a prevalence rate of 6%. The SSL-like dysplasia exhibited distinct clinicopathologic and molecular characteristics compared with its sporadic counterpart. Similarly, serrated dysplasia NOS displayed unique molecular features compared with SSL-like dysplasia and could carry a higher risk of malignancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Albert Szent-Györgyi Medical School, University of Szeged, 6725 Szeged, Hungary.
- Department of Medical Physics and Informatics, Albert Szent-Györgyi Medical School, University of Szeged, 6720 Szeged, Hungary.
- Department of Surgical and Molecular Pathology, Tumor Pathology Center, National Institute of Oncology, 1122 Budapest, Hungary.
- Department of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Hungary.
- HUN-REN-ONKOL-TTK-HCEMM Oncogenomics Research Group, National Institute of Oncology, 1122 Budapest, Hungary.
- Department of Pathology, University of California at San Francisco, San Francisco, CA 94143, USA.
ORCID-Profile: Tamás Lantos, Levente Kuthi, Anita Sejben
Förderung
- University of Szeged
- Albert Szent-Györgyi Medical School, Faculty Research Fund, Géza Hetényi Fund
Zitieren
APA
Balajthy, Z., Almási, S., Lantos, T., Kuthi, L., Deftereos, G., Choi, W. T., & Sejben, A. (2025). Whole-Exome Sequencing Analysis of Inflammatory Bowel Disease-Associated Serrated Dysplasia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26125704
Vancouver
Balajthy Z, Almási S, Lantos T, Kuthi L, Deftereos G, Choi WT, et al. Whole-Exome Sequencing Analysis of Inflammatory Bowel Disease-Associated Serrated Dysplasia. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26125704
BibTeX
@article{Balajthy2025,
author = {Balajthy, Zsófia and Almási, Szintia and Lantos, Tamás and Kuthi, Levente and Deftereos, Georgios and Choi, Won-Tak and Sejben, Anita},
title = {Whole-Exome Sequencing Analysis of Inflammatory Bowel Disease-Associated Serrated Dysplasia},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26125704}
}
EUVIMED